Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Heil

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Oncoimmunology|March 5, 2016
Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patientsCarlo Fremd, Stefan Stefanovic, Philipp Beckhove, et al.
Oncotargets and Therapy|July 29, 2016
Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trialAlexandra von Au, Eva Milloth, Ingo Diel, et al.
Archives of Gynecology and Obstetrics|February 9, 2017
Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center studyAlexandra von Au, Mona Klotzbuecher, Lorenz Uhlmann, et al.
Annals of Surgical Oncology|October 16, 2015
Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?B Schaefgen, M Mati, H P Sinn, et al.
Cancer Immunology, Immunotherapy : CII|December 17, 2010
Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patientsChristoph Domschke, Florian Schuetz, Yingzi Ge, et al.
Archives of Gynecology and Obstetrics|December 14, 2017
Oncotype DX<sup>®</sup> in breast cancer patients: clinical experience, outcome and follow-up-a case-control studyMichelle G Rath, Lorenz Uhlmann, Marita Fiedler, et al.
British Journal of Cancer|November 12, 2015
Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniquesJoerg Heil, Sherko Kümmel, Benedikt Schaefgen, et al.
Anti-Cancer Drugs|November 20, 2013
Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancerJoachim Rom, Sarah Bechstein, Christoph Domschke, et al.
Archives of Gynecology and Obstetrics|August 18, 2022
Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancerAlexandra von Au, Samra Shencoru, Lorenz Uhlmann, et al.
Cancer Immunology, Immunotherapy : CII|April 19, 2013
Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trialChristoph Domschke, Yingzi Ge, Isa Bernhardt, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Oncoimmunology|March 5, 2016
Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patientsCarlo Fremd, Stefan Stefanovic, Philipp Beckhove, et al.
Oncotargets and Therapy|July 29, 2016
Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trialAlexandra von Au, Eva Milloth, Ingo Diel, et al.
Archives of Gynecology and Obstetrics|February 9, 2017
Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center studyAlexandra von Au, Mona Klotzbuecher, Lorenz Uhlmann, et al.
Annals of Surgical Oncology|October 16, 2015
Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?B Schaefgen, M Mati, H P Sinn, et al.
Cancer Immunology, Immunotherapy : CII|December 17, 2010
Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patientsChristoph Domschke, Florian Schuetz, Yingzi Ge, et al.
Archives of Gynecology and Obstetrics|December 14, 2017
Oncotype DX<sup>®</sup> in breast cancer patients: clinical experience, outcome and follow-up-a case-control studyMichelle G Rath, Lorenz Uhlmann, Marita Fiedler, et al.
British Journal of Cancer|November 12, 2015
Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniquesJoerg Heil, Sherko Kümmel, Benedikt Schaefgen, et al.
Anti-Cancer Drugs|November 20, 2013
Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancerJoachim Rom, Sarah Bechstein, Christoph Domschke, et al.
Archives of Gynecology and Obstetrics|August 18, 2022
Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancerAlexandra von Au, Samra Shencoru, Lorenz Uhlmann, et al.
Cancer Immunology, Immunotherapy : CII|April 19, 2013
Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trialChristoph Domschke, Yingzi Ge, Isa Bernhardt, et al.
Pageof 10